AEI scholars have been researching the government's role in pharmaceutical regulation, drug safety policies, prescription drugs, and the effectiveness of the Food and Drug Administration--including regulations that slow progress in drug R&D. ‣‣‣ The United States is not immune to lethal failings in the quality of pharmaceutical drugs. With little realistic oversight, and more importantly, little ethos of business integrity in China, a major tragedy in the U.S. from a Chinese export is likely in the near future, writes Roger Bate in his article "How Safe Are Medicines Sold In the US?." U.S. consumers are unknowingly accepting higher risks than just a few years ago--cost pressures are understandable, but any sourcing from unapproved suppliers needs to stop now. [Read More]
|